BeOne Medicines (ONC) Asset Utilization Ratio (2016 - 2026)
BeOne Medicines (ONC) reported Asset Utilization Ratio of 0.69 for Q1 2026, down 3.44% year-over-year from 0.71 in Q1 2025, and up 1.51% on a QoQ basis from 0.68 in Q4 2025.
BeOne Medicines (ONC) has 11 years of Asset Utilization Ratio data on file, last reported at 0.69 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 3.44% year-over-year to 0.69 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.69 (down 3.44% YoY) and the FY2025 annual result came in at 0.76, up 16.54% from the prior year.
- Asset Utilization Ratio advanced to 0.69 in Q1 2026 per ONC's latest filing, from 0.68 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.75 in Q2 2025 and bottomed at 0.11 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.48 (2024), against an average of 0.46.
- The widest annual swing landed in 2022, when Asset Utilization Ratio retreated 29.87%; it then soared 157.0% in 2023.
- Tracing ONC's Asset Utilization Ratio over 5 years: stood at 0.23 in 2022, then surged by 87.09% to 0.43 in 2023, then surged by 49.41% to 0.65 in 2024, then grew by 4.16% to 0.68 in 2025, then climbed by 1.51% to 0.69 in 2026.
- Per Business Quant, the three latest ONC Asset Utilization Ratio figures stand at 0.69 (Q1 2026), 0.68 (Q4 2025), and 0.71 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.47 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.37 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.29 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.85 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.69 |
| Dec 31, 2025 | 0.68 |
| Sep 30, 2025 | 0.71 |
| Jun 30, 2025 | 0.75 |
| Mar 31, 2025 | 0.71 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.57 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.39 |
| Jun 30, 2023 | 0.31 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.23 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.14 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.17 |
| Mar 31, 2021 | 0.15 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.06 |
| Jun 30, 2020 | 0.06 |
| Mar 31, 2020 | 0.11 |
| Dec 31, 2019 | 0.19 |
| Sep 30, 2019 | 0.17 |
| Jun 30, 2019 | 0.16 |
| Mar 31, 2019 | 0.11 |
| Dec 31, 2018 | 0.09 |
| Sep 30, 2018 | 0.08 |
| Jun 30, 2018 | 0.19 |
| Mar 31, 2018 | 0.20 |
| Dec 31, 2017 | 0.23 |
| Sep 30, 2017 | 0.29 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.02 |
| Jun 30, 2016 | 0.03 |
| Mar 31, 2016 | 0.04 |